The results of the BIOVASC trial allow us to perform an immediate complete revascularization in patients with myocardial infarction and multivessel disease. Hospital La Paz made a great contribution to this trial. @CardioHULP @TheLancet
Raul Moreno
@RaulmorenoMD
Head of Cardiology, University Hospital La Paz, Madrid, Spain.
204 Following 1.6K Followers 303 Posts
Latest posts 5
Our study related with the consequences of cancelling elective invasive cardiac procedures during COVID-19 outbreak has been recognized as a top cited paper in Catheterization Cardiovascular Interventions in 2021-2022. Congratulations to all centers that contributed to the study.
First patient included in the TRANSFORM-II trial in Hospital La Paz with our friend Dr. Cortesse from Milano. @Hemodin_LaPaz @shci_sec @AJuradoRoman @hemodin90 @BernardCortese @Dr_DanielTebar @SilvioVeraV2 @ClaraUgueto
La investigación en los hospitales beneficia a los pacientes: Los hospitales que publican estudios de investigación tienen tasas de mortalidad de pacientes más bajas - @secardiologia @shci_sec gacetamedica.com/investigacion/…
More data supporting the use of intracoronary imaging in acute myocardial infarction. Less TVR and mortality vs angioplasty-guided PCI. doi.org/10.1016/j.ijca… @shci_sec @secardiologia